Nivolumab for the treatment of hepatocellular carcinoma. [electronic resource]
Producer: 20210112Description: 687-693 p. digitalISSN:- 1744-7682
- Antineoplastic Agents, Immunological -- immunology
- Carcinoma, Hepatocellular -- drug therapy
- Clinical Trials as Topic
- Drug Therapy, Combination
- Humans
- Ipilimumab -- therapeutic use
- Liver Neoplasms -- drug therapy
- Nivolumab -- immunology
- Programmed Cell Death 1 Receptor -- immunology
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.